The HHS Office of Inspector General (OIG) issues an unfavorable advisory opinion regarding the provision of a value-added free hearing aid; the OIG issues comprehensive general compliance program guidance; the FDA issues an FAQ regarding providing scientific information on unapproved uses for cleared/approved medical products; and the U.S. Department of Justice continues its fraud enforcement activities in the durable medical equipment space.